Suppr超能文献

配体结合的结构和动力学决定因素以及病理性激活剂 p25 和抑制肽 CIP 对细胞周期蛋白依赖性激酶 5 的调节作用。

Structural and dynamic determinants of ligand binding and regulation of cyclin-dependent kinase 5 by pathological activator p25 and inhibitory peptide CIP.

机构信息

Information Technology Laboratory, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA.

出版信息

J Mol Biol. 2010 Aug 20;401(3):478-92. doi: 10.1016/j.jmb.2010.06.040. Epub 2010 Jun 25.

Abstract

The crystal structure of the cdk5/p25 complex has provided information on possible molecular mechanisms of the ligand binding, specificity, and regulation of the kinase. Comparative molecular dynamics simulations are reported here for physiological conditions. This study provides new insight on the mechanisms that modulate such processes, which may be exploited to control pathological activation by p25. The structural changes observed in the kinase are stabilized by a network of interactions involving highly conserved residues within the cyclin-dependent kinase (cdk) family. Collective motions of the proteins (cdk5, p25, and CIP) and their complexes are identified by principal component analysis, revealing two conformational states of the activation loop upon p25 complexation, which are absent in the uncomplexed kinase and not apparent from the crystal. Simulations of the uncomplexed inhibitor CIP show structural rearrangements and increased flexibility of the interfacial loop containing the critical residue E240, which becomes fully hydrated and available for interactions with one of several positively charged residues in the kinase. These changes provide a rationale for the observed high affinity and enhanced inhibitory action of CIP when compared to either p25 or the physiological activators of cdk5.

摘要

该 cdk5/p25 复合物的晶体结构提供了关于配体结合、特异性和激酶调节的可能分子机制的信息。这里报告了生理条件下的比较分子动力学模拟。这项研究为调节这些过程的机制提供了新的见解,这些机制可能被用来控制 p25 的病理性激活。在激酶中观察到的结构变化通过涉及细胞周期蛋白依赖性激酶(cdk)家族内高度保守残基的相互作用网络得到稳定。通过主成分分析鉴定了蛋白质(cdk5、p25 和 CIP)及其复合物的集体运动,揭示了 p25 复合物化后激活环的两种构象状态,在未复合的激酶中不存在,也不是晶体中明显的。未复合抑制剂 CIP 的模拟显示结构重排和包含关键残基 E240 的界面环的柔韧性增加,该残基完全水合并可与激酶中的几个正电荷残基之一相互作用。这些变化为 CIP 与 p25 或 cdk5 的生理激活剂相比表现出的高亲和力和增强的抑制作用提供了合理的解释。

相似文献

8
9
Mechanism of CDK5/p25 binding by CDK inhibitors.CDK抑制剂与CDK5/p25结合的机制。
J Med Chem. 2005 Feb 10;48(3):671-9. doi: 10.1021/jm049323m.

引用本文的文献

本文引用的文献

2
Quantification and its applications in fluorescent microscopy imaging.荧光显微镜成像中的定量分析及其应用。
Traffic. 2009 Aug;10(8):951-61. doi: 10.1111/j.1600-0854.2009.00938.x. Epub 2009 May 5.
4
CHARMM: the biomolecular simulation program.CHARMM:生物分子模拟程序。
J Comput Chem. 2009 Jul 30;30(10):1545-614. doi: 10.1002/jcc.21287.
8
Scalable molecular dynamics with NAMD.使用 NAMD 的可扩展分子动力学
J Comput Chem. 2005 Dec;26(16):1781-802. doi: 10.1002/jcc.20289.
10
Mechanism of CDK5/p25 binding by CDK inhibitors.CDK抑制剂与CDK5/p25结合的机制。
J Med Chem. 2005 Feb 10;48(3):671-9. doi: 10.1021/jm049323m.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验